LIQUIDMETAL TECHNOLOGIES INC
Datakwaliteit: 83%
LQMT
OTC
Manufacturing
Chemicals
€ 0,11
▲
€ 0,01
(10,00%)
Marktkapitalisatie: 100,90 M
Prijs
€ 0,11
Marktkapitalisatie
100,90 M
Dagbereik
€ 0,10 — € 0,11
52-Weeksbereik
€ 0,07 — € 0,16
Volume
45.310
Openen € 0,11
50D / 200D Gem.
€ 0,12
4,35% below
50D / 200D Gem.
€ 0,13
12,49% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -2,76 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-8,37%
Boven sectorgemiddelde (-53,41%)
ROIC-10,57%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio10,55
Interest CoverageN/A
Waardering
PE (TTM)
-43,10
Onder sectorgemiddelde (-1,48)
P/B Ratio3,64
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -43,1 | -1,5 |
| P/B | 3,6 | 1,6 |
| ROE % | -8,4 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2,34 M |
| ROE | -8,37% | ROA | -7,97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -2,76 M |
| ROIC | -10,57% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 10,55 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 13,44 M | Tangible Book Value | 27,70 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -43,10 | Forward P/E | N/A |
| P/B Ratio | 3,64 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -2,73% | ||
| Market Cap | 100,90 M | Enterprise Value | 92,41 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 117,73% |
| SBC-Adj. FCF | -2,92 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 383.000,0 | 811.000,0 |
| Net Income | -2,34 M | -1,51 M | -2,05 M | -2,39 M | -3,38 M |
| EPS (Diluted) | — | — | 0,00 | 0,00 | 0,00 |
| Gross Profit | 230.000,0 | 217.000,0 | 149.000,0 | 67.000,0 | 183.000,0 |
| Operating Income | -3,74 M | -3,31 M | -3,09 M | -3,05 M | -4,06 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 14.000,0 | 19.000,0 | 20.000,0 | 55.000,0 | 84.000,0 |
| SG&A Expenses | 3,96 M | 3,51 M | 3,21 M | 3,06 M | 4,16 M |
| D&A | 325.000,0 | 327.000,0 | 335.000,0 | 344.000,0 | 375.000,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,11 M | 30,40 M | 31,84 M | 33,34 M | 35,61 M |
| Total Liabilities | 2,03 M | 1,26 M | 1,25 M | 1,30 M | 1,31 M |
| Shareholders' Equity | 27,09 M | 29,14 M | 30,59 M | 32,04 M | 34,29 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 7,16 M | 6,01 M | 8,84 M | 2,27 M | 4,09 M |
| Current Assets | 13,52 M | 16,12 M | 22,80 M | 19,28 M | 18,64 M |
| Current Liabilities | 1,53 M | 1,26 M | 344.000,0 | 394.000,0 | 414.000,0 |
{"event":"ticker_viewed","properties":{"ticker":"LQMT","listing_kind":"stock","pathname":"/stocks/lqmt","exchange":"OTC","country":"US"}}